Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Effect of Bicarbonate-Buffered Dialysate on Ventricular Arrhythmias in Hemodialysis Patients.

Krahn RE, Tulowitzki R, Gudleski GD, Murray B, Rajagopalan B, Su W, Muscarella M, Lambert J, Curtis AB, Panesar M.

Am J Nephrol. 2019;49(1):74-80. doi: 10.1159/000495846. Epub 2019 Jan 2.

PMID:
30602157
2.

Definition and Validation of a Novel Metric of Erythropoiesis-Stimulating Agent Response in Hemodialysis Patients.

Meaney CJ, Karas S, Robinson B, Gaesser J, Forrest A, Krzyzanski W, Panesar M, Rao GG.

J Clin Pharmacol. 2019 Mar;59(3):418-426. doi: 10.1002/jcph.1330. Epub 2018 Nov 9.

PMID:
30412269
3.

Barriers, Facilitators, and Solutions to Optimal Patient Portal and Personal Health Record Use: A Systematic Review of the Literature.

Zhao JY, Song B, Anand E, Schwartz D, Panesar M, Jackson GP, Elkin PL.

AMIA Annu Symp Proc. 2018 Apr 16;2017:1913-1922. eCollection 2017.

4.

Changes in Serum Bicarbonate Levels Caused by Acetate-Containing Bicarbonate-Buffered Hemodialysis Solution: An Observational Prospective Cohort Study.

Panesar M, Shah N, Vaqar S, Ivaturi K, Gudleski G, Muscarella M, Lambert J, Su W, Murray B.

Ther Apher Dial. 2017 Apr;21(2):157-165. doi: 10.1111/1744-9987.12510. Epub 2017 Mar 13.

PMID:
28296160
5.

Multidisciplinary approach to the management of a case of classical respiratory diphtheria requiring percutaneous endoscopic gastrostomy feeding.

Haywood MJ, Vijendren A, Acharya V, Mulla R, Panesar MJ.

BMJ Case Rep. 2017 Mar 6;2017. pii: bcr2016218408. doi: 10.1136/bcr-2016-218408.

6.

Involvement of the renin-angiotensin system in the development of nephrogenic systemic fibrosis-like lesions in the RenTag mouse model.

Sexton S, Tulowitzki R, Jones CA, Shah S, Hajduczok G, Gross KW, Panesar M.

Clin Exp Nephrol. 2016 Apr;20(2):162-8. doi: 10.1007/s10157-015-1141-z. Epub 2015 Jul 3.

7.

Evaluation of a Renal Transplant Program for Incarcerated ESRD Patients.

Panesar M, Bhutani H, Blizniak N, Gundroo A, Zachariah M, Pelley W, Venuto R.

J Correct Health Care. 2014 Jul;20(3):220-227. Epub 2014 Jun 16.

PMID:
24934840
8.

Discovery, optimization, and biological evaluation of 5-(2-(trifluoromethyl)phenyl)indazoles as a novel class of transient receptor potential A1 (TRPA1) antagonists.

Rooney L, Vidal A, D'Souza AM, Devereux N, Masick B, Boissel V, West R, Head V, Stringer R, Lao J, Petrus MJ, Patapoutian A, Nash M, Stoakley N, Panesar M, Verkuyl JM, Schumacher AM, Petrassi HM, Tully DC.

J Med Chem. 2014 Jun 26;57(12):5129-40. doi: 10.1021/jm401986p. Epub 2014 Jun 13.

PMID:
24884675
9.

The medical-legal responsibilities of a dialysis unit medical director.

Vaqar S, Murray B, Panesar M.

Semin Dial. 2014 Sep-Oct;27(5):472-6. doi: 10.1111/sdi.12174. Epub 2013 Dec 12. Review.

PMID:
24329720
10.

Understanding nephrogenic systemic fibrosis.

Chopra T, Kandukurti K, Shah S, Ahmed R, Panesar M.

Int J Nephrol. 2012;2012:912189. doi: 10.1155/2012/912189. Epub 2012 Nov 4.

11.
12.

Pasteurella multocida peritonitis with bacteremia on initiation of peritoneal dialysis.

Weiss GA, Panesar M.

Perit Dial Int. 2012 May-Jun;32(3):363-4. doi: 10.3747/pdi.2011.00191. No abstract available.

13.

7-tert-Butyl-6-(4-chloro-phenyl)-2-thioxo-2,3-dihydro-1H-pyrido[2,3-d]pyrimidin-4-one, a classic polymodal inhibitor of transient receptor potential vanilloid type 1 with a reduced liability for hyperthermia, is analgesic and ameliorates visceral hypersensitivity.

Nash MS, McIntyre P, Groarke A, Lilley E, Culshaw A, Hallett A, Panesar M, Fox A, Bevan S.

J Pharmacol Exp Ther. 2012 Aug;342(2):389-98. doi: 10.1124/jpet.112.191932. Epub 2012 May 7.

PMID:
22566669
14.

Increased prokineticin 2 expression in gut inflammation: role in visceral pain and intestinal ion transport.

Watson RP, Lilley E, Panesar M, Bhalay G, Langridge S, Tian SS, McClenaghan C, Ropenga A, Zeng F, Nash MS.

Neurogastroenterol Motil. 2012 Jan;24(1):65-75, e12. doi: 10.1111/j.1365-2982.2011.01804.x. Epub 2011 Nov 3.

PMID:
22050240
15.

What is the role of renal transplantation in a patient with nephrogenic systemic fibrosis?

Panesar M, Yacoub R.

Semin Dial. 2011 Jul-Aug;24(4):373-4. doi: 10.1111/j.1525-139X.2011.00913.x. No abstract available.

PMID:
21851392
16.

Transmetallation and gadolinium: do low iron stores prevent the development of nephrogenic systemic fibrosis in high-risk end-stage renal disease patients?

Panesar M, Boateng F, Patel SS, Masood SF, Mahajan P, Patel N, Murray B.

Hemodial Int. 2010 Jul;14(3):289-94. doi: 10.1111/j.1542-4758.2010.00456.x.

PMID:
20662951
17.

Use of anti-CD20 antibody in the treatment of post-transplant glomerulonephritis.

Damodar A, Mustafa R, Bhatnagar J, Panesar M, Gundroo A, Zachariah M, Blessios G, Tornatore K, Weber-Shrikant E, Venuto R.

Clin Transplant. 2011 May-Jun;25(3):375-9. doi: 10.1111/j.1399-0012.2010.01245.x. Epub 2010 Apr 5.

PMID:
20384712
18.

Periodontitis and chronic kidney disease.

Scannapieco FA, Panesar M.

J Periodontol. 2008 Sep;79(9):1617-9. doi: 10.1902/jop.2008.080313 . No abstract available. Erratum in: J Periodontol. 2008 Oct;79(10 ):2010. J Periodontol. 2008 Oct;79(10):2010.

PMID:
18771360
19.

Aliskiren combined with losartan in diabetes and nephropathy.

Panesar M, Damodar A.

N Engl J Med. 2008 Sep 4;359(10):1068; author reply 1069-70. doi: 10.1056/NEJMc081393. No abstract available.

PMID:
18768954
20.

Dialysis disequilibrium syndrome: a narrative review.

Patel N, Dalal P, Panesar M.

Semin Dial. 2008 Sep-Oct;21(5):493-8. doi: 10.1111/j.1525-139X.2008.00474.x. Epub 2008 Aug 28. Review.

PMID:
18764799
21.

Clinical improvement of nephrogenic systemic fibrosis after kidney transplantation.

Panesar M, Banerjee S, Barone GW.

Clin Transplant. 2008 Nov-Dec;22(6):803-8. doi: 10.1111/j.1399-0012.2008.00886.x. Epub 2008 Aug 18.

PMID:
18713261
22.

Nephrogenic systemic fibrosis.

Nainani N, Panesar M.

Am J Nephrol. 2009;29(1):1-9. doi: 10.1159/000149628. Epub 2008 Jul 29. Review.

23.

Vancomycin-induced immune thrombocytopenia.

Panesar M.

N Engl J Med. 2007 Jun 14;356(24):2537; author reply 2537-8. No abstract available.

PMID:
17568037
24.

Long-term outcome of renal transplantation from older donors.

Panesar M, Kumar J, Abul-Ezz S.

N Engl J Med. 2006 May 11;354(19):2071-4; author reply 2071-4. No abstract available.

PMID:
16696142
25.

Identification and biological characterization of 6-aryl-7-isopropylquinazolinones as novel TRPV1 antagonists that are effective in models of chronic pain.

Culshaw AJ, Bevan S, Christiansen M, Copp P, Davis A, Davis C, Dyson A, Dziadulewicz EK, Edwards L, Eggelte H, Fox A, Gentry C, Groarke A, Hallett A, Hart TW, Hughes GA, Knights S, Kotsonis P, Lee W, Lyothier I, McBryde A, McIntyre P, Paloumbis G, Panesar M, Patel S, Seiler MP, Yaqoob M, Zimmermann K.

J Med Chem. 2006 Jan 26;49(2):471-4.

PMID:
16420034
26.

What does tumour necrosis factor excess do to the immune system long term?

Clark J, Vagenas P, Panesar M, Cope AP.

Ann Rheum Dis. 2005 Nov;64 Suppl 4:iv70-6. Review.

27.

Pathways of T cell activation and terminal differentiation in chronic inflammation.

Isomäki P, Clark JM, Panesar M, Cope AP.

Curr Drug Targets Inflamm Allergy. 2005 Jun;4(3):287-93. Review.

PMID:
16101535
28.

Cerebrospinal fluid leak mimicking allergic rhinitis.

Ricketti AJ, Cleri DJ, Porwancher RB, Panesar M, Villota FJ, Seelagy MM.

Allergy Asthma Proc. 2005 Mar-Apr;26(2):125-8.

PMID:
15971471
29.

Antihyperalgesic activity of a novel nonpeptide bradykinin B1 receptor antagonist in transgenic mice expressing the human B1 receptor.

Fox A, Kaur S, Li B, Panesar M, Saha U, Davis C, Dragoni I, Colley S, Ritchie T, Bevan S, Burgess G, McIntyre P.

Br J Pharmacol. 2005 Apr;144(7):889-99.

30.

T cell receptor zeta reconstitution fails to restore responses of T cells rendered hyporesponsive by tumor necrosis factor alpha.

Clark JM, Annenkov AE, Panesar M, Isomäki P, Chernajovsky Y, Cope AP.

Proc Natl Acad Sci U S A. 2004 Feb 10;101(6):1696-701. Epub 2004 Jan 26.

31.

The VR1 antagonist capsazepine reverses mechanical hyperalgesia in models of inflammatory and neuropathic pain.

Walker KM, Urban L, Medhurst SJ, Patel S, Panesar M, Fox AJ, McIntyre P.

J Pharmacol Exp Ther. 2003 Jan;304(1):56-62.

PMID:
12490575
32.

Prolonged exposure of T cells to TNF down-regulates TCR zeta and expression of the TCR/CD3 complex at the cell surface.

Isomäki P, Panesar M, Annenkov A, Clark JM, Foxwell BM, Chernajovsky Y, Cope AP.

J Immunol. 2001 May 1;166(9):5495-507.

33.

In vivo pharmacology of SDZ 249-665, a novel, non-pungent capsaicin analogue.

Urban L, Campbell EA, Panesar M, Patel S, Chaudhry N, Kane S, Buchheit K, Sandells B, James IF.

Pain. 2000 Dec 15;89(1):65-74.

PMID:
11113294
34.

Metabotropic glutamate receptor subtype 5 (mGlu5) and nociceptive function. I. Selective blockade of mGlu5 receptors in models of acute, persistent and chronic pain.

Walker K, Bowes M, Panesar M, Davis A, Gentry C, Kesingland A, Gasparini F, Spooren W, Stoehr N, Pagano A, Flor PJ, Vranesic I, Lingenhoehl K, Johnson EC, Varney M, Urban L, Kuhn R.

Neuropharmacology. 2001;40(1):1-9.

PMID:
11077065
35.

Analgesic profile of the nicotinic acetylcholine receptor agonists, (+)-epibatidine and ABT-594 in models of persistent inflammatory and neuropathic pain.

Kesingland AC, Gentry CT, Panesar MS, Bowes MA, Vernier JM, Cube R, Walker K, Urban L.

Pain. 2000 May;86(1-2):113-8.

PMID:
10779668
36.

Cyclooxygenases-1 and 2 couple to cytosolic but not group IIA phospholipase A2 in COS-1 cells.

Takano T, Panesar M, Papillon J, Cybulsky AV.

Prostaglandins Other Lipid Mediat. 2000 Jan;60(1-3):15-26.

PMID:
10680772
37.

Increased binding of fibrinogen to glycoprotein IIIa-proline33 (HPA-1b, PlA2, Zwb) positive platelets in patients with cardiovascular disease.

Goodall AH, Curzen N, Panesar M, Hurd C, Knight CJ, Ouwehand WH, Fox KM.

Eur Heart J. 1999 May;20(10):742-7.

PMID:
10329065
38.

Selective neurokinin-1 receptor antagonists are anti-hyperalgesic in a model of neuropathic pain in the guinea-pig.

Campbell EA, Gentry CT, Patel S, Panesar MS, Walpole CS, Urban L.

Neuroscience. 1998 Dec;87(3):527-32.

PMID:
9758219
39.

Increased platelet responsiveness following coronary stenting. Heparin as a possible aetiological factor in stent thrombosis.

Knight CJ, Panesar M, Wilson DJ, Patrineli A, Chronos N, Wright C, Clarke D, Patel D, Fox K, Goodall AH.

Eur Heart J. 1998 Aug;19(8):1239-48.

PMID:
9740346
40.

Altered platelet function detected by flow cytometry. Effects of coronary artery disease and age.

Knight CJ, Panesar M, Wright C, Clarke D, Butowski PS, Patel D, Patrineli A, Fox K, Goodall AH.

Arterioscler Thromb Vasc Biol. 1997 Oct;17(10):2044-53.

PMID:
9351370
41.

Activation of phospholipase A2 by complement C5b-9 in glomerular epithelial cells.

Panesar M, Papillon J, McTavish AJ, Cybulsky AV.

J Immunol. 1997 Oct 1;159(7):3584-94.

PMID:
9317158
42.

Different effects of calcium antagonists, nitrates, and beta-blockers on platelet function. Possible importance for the treatment of unstable angina.

Knight CJ, Panesar M, Wilson DJ, Chronos NA, Patel D, Fox K, Goodall AH.

Circulation. 1997 Jan 7;95(1):125-32.

PMID:
8994427
43.

Effects of diltiazem and its analogue siratiazem on contraction and 45Ca2+ uptake in sheep coronary artery rings.

Hagerty M, Panesar M, Wadsworth R, Kane K.

Gen Pharmacol. 1995 Oct;26(6):1349-54.

PMID:
7590130
44.

Comparison of the effects of diltiazem and its analogue siratiazem on contractility in arteries, ileum and cardiac muscle.

Panesar MS, Hagerty MJ, Kane KA, Wadsworth RM.

J Auton Pharmacol. 1995 Apr;15(2):107-13.

PMID:
7615573
45.
46.

Glycoconjugates of the normal human colorectum: a lectin histochemical study.

McMahon RF, Panesar MJ, Stoddart RW.

Histochem J. 1994 Jun;26(6):504-18.

PMID:
7928404
47.

Glycerol production by anaerobic vacuum fermentation of molasses on pilot scale.

Virkar PD, Panesar MS.

Biotechnol Bioeng. 1987 Apr;29(6):773-4. No abstract available.

PMID:
18576516

Supplemental Content

Loading ...
Support Center